Wii-IVR in GDH was feasible and most participants accepted it. Participants had more improvements in FIM.

Stigmatizing attitudes from health professionals toward people living with HIV (PLHIV) constitute a key barrier to HIV care. Despite considerable progress in HIV stigma-reduction research, we are still searching for effective strategies that can be implemented on a larger scale. To narrow this research gap, the present study investigated a novel cost-effective approach to reducing HIV-related stigma among health professionals. Interactive experiential games were used to help participants gain first-hand experience of potential stressors that PLHIV might encounter. The effectiveness of this game-based experiential approach was compared with that of in vivo contact in reducing HIV-related stigma among students in the health-care fields. Eighty-eight students of health-related programs in Hong Kong were randomly assigned to either the game-based or in vivo contact program. They completed measures of stigmatizing attitudes and HIV/AIDS-related knowledge at pre-program, post-program, and one-month follow-up. Findings showed that the effectiveness of the game-based experiential approach in reducing HIV-related stigma was similar to that of in vivo contact both at post-program and one-month follow-up. Further research is needed to explore the potential value of the game-based approach in reducing HIV stigma among health professionals.

symptomatic. Symptoms included cognitive decline/visual symptoms, optic ischaemic neuropathy/ auditory symptoms, nuchal pain & shoulder discomfort, instability whilst walking associated with a very high risk of falls & fracture, profound fatigue causing a state of marked dependency & house-bound for the most part of the inter-dialytic period. She received Midodrine 10 mg TDS, Fludrocortisone 100mcg & Erythropoietin.Droxidopa was commenced, in addition to other drugs, with 1 week of cardiac monitoring-No arrhythmias were recorded & LVOT gradient did not change at a dose of 400mg pre-dialysis at 0700 hours 3 times a week.The Orthostatic Hypotension Questionnaire (OHQ) was used to assess symptoms burden & severity of hypotension before commencing Droxidopa. Symptoms Diary was maintained by the patient throughout.Results: Table1 OHQ Scores Conclusions: Droxidopa 400 mg on dialysis days was well tolerated, achieved both symptomatic improvement & better blood pressure readings, both on HD & non-HD days during 4 months of follow up. Off label use can be considered in selected cases of difficult to manage hypotension in HD population, provided close & frequent monitoring can be offered.

No abstract